Molecular mechanism of the signaling pathways that induce dedifferentiation of smooth muscle cells

诱导平滑肌细胞去分化的信号通路分子机制

基本信息

  • 批准号:
    13670120
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

The phenotypic modulation of vascular smooth muscle cells (SMCs) from the differentiated state to the dedifferentiated one is critical event in the development and progression of atherosclerosis. However, the critical atherogenic factors remain unclear. We established primary culture systems for visceral and vascular SMCs in which both SMCs can maintain a differentiated phenotype, as indicated by a spindle-like shape, ligand-induced contractility, and a high level expression of SMC differentiation markers. In this study, we searched for critical SMC dedifferentiation factors using our culture systems. We found that polar lipids extracted from human serum markedly induced SMC dedifferentiation, and this activity was solely present in the lysophosphatidic acid (LPA) fraction. Among several LPA species detected in human serum lipids, unsaturated LPAs were identified as major contributors for SMC dedifferentiation. Unsaturated (18:1) LPA, but not saturated (18:0) LPA, strongly induced vascular SMC dedifferentiation in culture and vascular remodeling consisted of neointima in rat carotid arteriesin vivo. 18:1 LPA-induced vascular SMC dedifferentiation in culture and vascular remodelingin vivo were mediated through the coordinated activation of both ERK and p38 MAPK. The neointima was mainly derived from dedifferentiated medial vascular SMCs. During 18:1 LPA-induced vascular remodeling, the phenotypic modulation of medial vascular SMCs preceded macrophage infiltration. Thus, this study demonstrates the first finding that unsaturated LPAs, but not saturated LPAs, specifically induce vascular SMC phenotypic modulation, suggesting that these molecules could function as atherogenic factors.
血管平滑肌细胞(SMC)从分化状态向去分化状态的表型转变是动脉粥样硬化发生发展的关键事件。然而,致动脉粥样硬化的关键因素仍不清楚。我们建立了内脏和血管平滑肌细胞的原代培养系统,其中两种平滑肌细胞都可以保持分化的表型,如梭形形状,配体诱导的收缩性和高水平表达的平滑肌细胞分化标志物所示。在这项研究中,我们使用我们的培养系统寻找关键的SMC去分化因子。我们发现,从人血清中提取的极性脂质显着诱导SMC去分化,这种活动是唯一存在于溶血磷脂酸(LPA)馏分。在人血清脂质中检测到的几种LPA物质中,不饱和LPA被鉴定为SMC去分化的主要贡献者。不饱和(18:1)LPA(18:0)LPA(18:1)可明显诱导培养的大鼠颈动脉平滑肌细胞脱分化,并诱导由新生内膜组成的血管重构。18:1 LPA诱导的血管平滑肌细胞去分化和血管重塑是通过ERK和p38 MAPK协同激活介导的。新生内膜主要来源于去分化的中膜血管平滑肌细胞。在18:1 LPA诱导的血管重塑过程中,中膜血管平滑肌细胞的表型调节先于巨噬细胞浸润。因此,这项研究表明,第一个发现,不饱和的LPAs,而不是饱和的LPAs,特异性诱导血管SMC表型调制,这表明这些分子可以作为致动脉粥样硬化因子。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakamura M.: "Transcriptional activation of β-tropomyosin mediated by serum response factor and a novel Barx homologue, Barxlb, in smooth muscle cells"J. Biol. Chem.. 276. 18313-1832 (2000)
Nakamura M.:“平滑肌细胞中血清反应因子和新型 Barx 同源物 Barxlb 介导的 β-原肌球蛋白的转录激活”J. Biol. 276. 18313-1832 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishida W.: "A triad of SRF and the GATA and NK families governs the transcription of smooth and cardiac muscle genes"J. Biol. Chem.. 277. 7308-7317 (2002)
Nishida W.:“SRF、GATA 和 NK 家族的三联体控制平滑肌和心肌基因的转录”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
林 謙一郎: "平滑筋細胞形質転換の分子メカニズム"細胞The Cell. 33・9. 328-333 (2002)
林健一郎:“平滑肌细胞转化的分子机制”《细胞》33・9(2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashi K: "Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophoshatidic acids"Cir. Res. 89. 251-258 (2001)
Hayashi K:“不饱和溶血磷脂酸诱导的血管平滑肌细胞的表型调节”Cir。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
林 謙一郎: "分化型・脱分化型血管平滑筋細胞のシグナル伝達と転写制御機構"分子心血管病. 3. 647-657 (2002)
Kenichiro Hayashi:“分化和去分化血管平滑肌细胞的信号转导和转录控制机制”分子心血管疾病。 3. 647-657 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAYASHI Kenichiro其他文献

HAYASHI Kenichiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAYASHI Kenichiro', 18)}}的其他基金

Inter-ethnic Relationships in southwestern China in the 10-13th century
10-13世纪中国西南地区的民族关系
  • 批准号:
    16K03077
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ethnic Formation and Interaction in the Thirteenth and Fourteenth Century Yunnan
十三、十四世纪云南的民族形成与互动
  • 批准号:
    24520800
  • 财政年份:
    2012
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tradition of the historiography in the non-Han ethnic group in Yunnan, China
云南非汉族史学传统
  • 批准号:
    21520714
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Transcriptional regulation of caldesmon gene in smooth muscle cells
平滑肌细胞caldesmon基因的转录调控
  • 批准号:
    06836011
  • 财政年份:
    1994
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Apicidin启动成熟脂肪细胞去分化的分子信号机制研究
  • 批准号:
    81071589
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目

相似海外基金

Preventing dedifferentiation of neurons: a role for H3K9me- and HP1 associated heterochromatin?
防止神经元去分化:H3K9me 和 HP1 相关异染色质的作用?
  • 批准号:
    BB/X00256X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
ECM remodeling and crosstalk with cell fate in zebrafish ligament regeneration
斑马鱼韧带再生中 ECM 重塑和细胞命运的串扰
  • 批准号:
    10748627
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
剖析肿瘤细胞免疫 TME 轴,以确定可增强 GBM 免疫治疗的治疗上可操作的漏洞
  • 批准号:
    10743534
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
The role of the COP9 signalosome in distal nephron remodeling
COP9信号体在远端肾单位重塑中的作用
  • 批准号:
    10723624
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes
开发类视黄醇途径的一流拮抗剂作为 2 型糖尿病的新型口服疗法
  • 批准号:
    10699637
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
骨髓细胞驱动胰腺可塑性和致癌机制
  • 批准号:
    10607213
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Investigating mechanisms of oxidized phospholipid-mediated dysregulation of regulatory T cells in atherosclerosis
研究动脉粥样硬化中氧化磷脂介导的调节性 T 细胞失调的机制
  • 批准号:
    10648711
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Lung Myofibroblast De-Differentiation and Fibrosis Resolution Depend on cAMP-mediated Inhibition of HuR.
肺肌成纤维细胞去分化和纤维化消退取决于 cAMP 介导的 HuR 抑制。
  • 批准号:
    10661944
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
microRNA-483 regulation of pancreatic beta-cell function and identity
microRNA-483 对胰腺 β 细胞功能和身份的调节
  • 批准号:
    10580237
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Age-related mechanisms of altered tendon structure and function
肌腱结构和功能改变的年龄相关机制
  • 批准号:
    10678395
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了